Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

NCT00297167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Exocrine Pancreatic Insufficiency

Interventions

DRUG: EUR-1008 (APT-1008)
DRUG: Placebo
DRUG: Placebo
DRUG: EUR-1008 (APT-1008)

Sponsor

Forest Laboratories